These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8871647)

  • 1. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
    Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
    J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Several HLA alleles share overlapping peptide specificities.
    Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
    J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.
    Kondo A; Sidney J; Southwood S; del Guercio MF; Appella E; Sakamoto H; Celis E; Grey HM; Chesnut RW; Kubo RT; Sette A
    J Immunol; 1995 Nov; 155(9):4307-12. PubMed ID: 7594589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I MHC-peptide interaction: structural and functional aspects.
    Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
    Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Several common HLA-DR types share largely overlapping peptide binding repertoires.
    Southwood S; Sidney J; Kondo A; del Guercio MF; Appella E; Hoffman S; Kubo RT; Chesnut RW; Grey HM; Sette A
    J Immunol; 1998 Apr; 160(7):3363-73. PubMed ID: 9531296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules.
    Gnjatic S; Bressac-de Paillerets B; Guillet JG; Choppin J
    Eur J Immunol; 1995 Jun; 25(6):1638-42. PubMed ID: 7542198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
    Griffin TA; Yuan J; Friede T; Stevanovic S; Ariyoshi K; Rowland-Jones SL; Rammensee HG; Colbert RA
    J Immunol; 1997 Nov; 159(10):4887-97. PubMed ID: 9366414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
    J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype.
    Sidney J; Southwood S; Pasquetto V; Sette A
    J Immunol; 2003 Dec; 171(11):5964-74. PubMed ID: 14634108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic HLA-B7-restricted peptides of hTRT.
    Cortez-Gonzalez X; Sidney J; Adotevi O; Sette A; Millard F; Lemonnier F; Langlade-Demoyen P; Zanetti M
    Int Immunol; 2006 Dec; 18(12):1707-18. PubMed ID: 17077179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.
    Hildebrand WH; Madrigal JA; Little AM; Parham P
    J Immunol; 1992 Feb; 148(4):1155-62. PubMed ID: 1737933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
    Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
    J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.
    Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K
    Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B15 peptide ligands are preferentially anchored at their C termini.
    Prilliman KR; Jackson KW; Lindsey M; Wang J; Crawford D; Hildebrand WH
    J Immunol; 1999 Jun; 162(12):7277-84. PubMed ID: 10358176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of the affinity of HLA class I-binding peptides lacking primary anchor residues by manipulation of the secondary anchor residues.
    Rovero P; Viganò S; Pegoraro S; Revoltella R; Riganelli D; Fruci D; Greco G; Butler RH; Tanigaki N
    J Pept Sci; 1995; 1(4):266-73. PubMed ID: 9223004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs.
    McKinney DM; Erickson AL; Walker CM; Thimme R; Chisari FV; Sidney J; Sette A
    J Immunol; 2000 Oct; 165(8):4414-22. PubMed ID: 11035079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of specific peptide motifs for four major HLA-A alleles.
    Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
    J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations.
    Chen Y; Sidney J; Southwood S; Cox AL; Sakaguchi K; Henderson RA; Appella E; Hunt DF; Sette A; Engelhard VH
    J Immunol; 1994 Mar; 152(6):2874-81. PubMed ID: 8144888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of tum- peptide analogs define an alternative anchor that can be utilized by Ld ligands lacking the consensus P2 anchor.
    Robinson RA; Lee DR
    J Immunol; 1996 Jun; 156(11):4266-73. PubMed ID: 8666797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.